Quest Diagnostics Inc. Stock
Price
Target price
€167.45
€167.45
-2.340%
-4.0
-2.340%
€195.85
24.04.26 / Tradegate
WKN: 904533 / Symbol: DGX / Name: Quest Diagnostcs / Stock / Healthcare Providers & Services / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Quest Diagnostics Inc. Stock
We can see a decrease in the price for Quest Diagnostics Inc.. Compared to yesterday it has lost -€4.000 (-2.340%).
With 7 Buy predictions and not the single Sell prediction the community is currently very high on Quest Diagnostics Inc..
With a target price of 195 € there is a slightly positive potential of 16.45% for Quest Diagnostics Inc. compared to the current price of 167.45 €.
Pros and Cons of Quest Diagnostics Inc. in the next few years
Pros
?
M***** P*******
?
B****
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Quest Diagnostics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Quest Diagnostics Inc. | -2.340% | 3.014% | -0.829% | 9.266% | 12.270% | 26.712% | 54.474% |
| Anthem Inc. | -0.540% | 7.177% | 17.398% | -21.921% | -0.068% | -29.952% | -6.810% |
| HCA Holdings Inc. | -7.390% | -11.020% | -12.017% | 23.041% | -8.391% | 42.361% | 120.430% |
| Universal Health Services B | -4.490% | -3.871% | -7.453% | -2.614% | -22.396% | 16.406% | 23.909% |
Comments
Quest Diagnostics (DGX) had its price target raised by Barclays PLC from $225.00 to $230.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for DGX provided by MarketBeat
Quest Diagnostics (DGX) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
Show more
Ratings data for DGX provided by MarketBeat
Quest Diagnostics (NYSE:DGX) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Show more
Ratings data for DGX provided by MarketBeat